CRYSTAL WALLS: Open Payments
NPI 1396222998 · CUMBERLAND, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$654 in 44 payments from 10 companies in 2025. Trend: 2023 $640 · 2024 $558 · 2025 $654
Food & beverage: $654
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 26 | $300 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 8 | $151 |
| Indivior Inc. | 2 | $50 |
| AstraZeneca Pharmaceuticals LP | 2 | $33 |
| Braeburn Inc. | 1 | $26 |
| Alkermes, Inc. | 1 | $23 |
| Novo Nordisk Inc | 1 | $20 |
| Exact Sciences Corporation | 1 | $19 |
| Axsome Therapeutics, Inc. | 1 | $17 |
| Amgen Inc. | 1 | $16 |
Products named: VRAYLAR, CAPLYTA, SUBLOCADE, BRIXADI, ARISTADA, Wegovy, Cologuard Collection Kit, AIRSUPRA.
Industry payments across MD — which companies pay providers there.
